As of Nov 19, 2026, 1 of 2 active firms rate PIII a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PIII EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect P3 Health Partners Inc to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $-4.48, growing to $-11.72 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 0 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $1.6B, rising to $1.7B next year.
Top analysts covering P3 Health Partners Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PIII.
#1
BH
Ben Haynor
Lake Street
Buy
$14.00+566.7% to target
Coverage
—
+ Follow
#2
Ryan Langston
TD Cowen
Neutral
$14.00+566.7% to target
Coverage
—
+ Follow
#3
David Larsen
BTIG
Neutral
No targeton PIII
Coverage
—
+ Follow
#4
BO
Brooks O'Neil
Lake Street
Buy
$20.00+852.4% to target
Coverage
—
+ Follow
#5
GT
Gary Taylor
TD Cowen
Neutral
$0.25-88.1% to target
Coverage
—
+ Follow
PIII stock forecast FAQ
What is PIII's average 12-month price target?+
The 2 active firms with a live target average $14.00 for P3 Health Partners Inc over the next 12 months, ranging from a $14.00 high to a $14.00 low, as of Nov 19, 2026.
Is PIII stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover PIII?+
2 active firms have a recognized rating on P3 Health Partners Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PIII?+
Among analysts who currently cover PIII, Ben Haynor of Lake Street has the strongest overall Quantellect track record. Their current call is Buy with a $14.00 target.
What is P3 Health Partners Inc's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts. Full-year EPS is projected at $-4.48, rising to $-11.72 the following year.
How much revenue is P3 Health Partners Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $1.6B, growing to $1.7B next year.
Have analysts been upgrading or downgrading PIII lately?+
As of Nov 19, 2026, 1 of 2 active firms rate PIII a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PIII calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.